Finance

Beta
Lists
SONM:NASDAQ
DNA X Inc
$5.01
+5.47%
(+0.26) 1D
Jun 8, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SONM...
Open
$4.67
High
$5.14
Low
$4.67
Mkt. cap
7.46M
Avg. vol.
22.22K
Volume
11.92K
52-wk high
$38.52
52-wk low
$2.52
EPS
-$22.46
Beta
1.86
Shares outstanding
1.49M
No. of employees
4
Open
$4.67
High
$5.14
Low
$4.67
Mkt. cap
7.46M
Avg. vol.
22.22K
Volume
11.92K
52-wk high
$38.52
52-wk low
$2.52
EPS
-$22.46
Beta
1.86
Shares outstanding
1.49M
No. of employees
4
News stories
From sources across the web
About DNA X Inc
CEO-
Employees4
Founded1999
Headquarters-
SectorComputers, Peripherals, and Software
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
11.19M
16.21M
-
-
Cost of goods sold
10.34M
14.40M
-
-
Cost of revenue
10.34M
14.40M
-
-
Research and development expenses
909.00K
181.00K
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.67M
5.62M
-
3.62M
Operating expense
7.58M
5.80M
-
3.62M
Total operating expenses
17.92M
20.19M
-
3.62M
Operating income
-6.73M
-3.98M
-
-3.62M
Other non operating income
380.00K
-161.00K
-
-227.00K
EBT including unusual items
-7.34M
-4.66M
-
-3.93M
EBT excluding unusual items
-6.74M
-4.66M
-
-3.93M
Income tax expense
139.00K
90.00K
-
-
Effective tax rate
-1.89%
-1.93%
-
-
Other operating expenses
-
-
-
-
Net income
-7.48M
-4.75M
-
6.34M
Net profit margin
-66.80%
-29.31%
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-389.00K
-522.00K
-
-131.00K
Net interest expenses
-389.00K
-522.00K
-
-131.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.94M
-3.03M
-
-2.54M
Gain or loss from assets sale
-
-
-
-15.56M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more